Nexvet Biopharma plc (NVET) is a publicly traded company in the Unknown sector. Across all available filings, 21 corporate insiders have executed 233 transactions totaling $5.5M, demonstrating a bullish sentiment with $5.5M in net insider flow. The most recent transaction on Jul 31, 2017 involved a transaction of 209,577 shares valued at $1.4M.
No significant insider buying has been recorded for NVET in the recent period.
No significant insider selling has been recorded for NVET in the recent period.
Based on recent SEC filings, insider sentiment for NVET is bullish with an Insider Alignment Score of 100/100 and a net flow of $5.5M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at Nexvet Biopharma plc (NVET) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 21 insiders are actively trading NVET stock, having executed 233 transactions in the past 90 days. The most active insider is L.l.c. Ngp, (Executive), who has made 24 transactions totaling $67.4M.
Get notified when executives and directors at NVET file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Jul 31, 2017 | Ngp, L.l.c. | Executive | Tender | 209,577 | $6.72 | $1.4M | Large |
| Jul 31, 2017 | Ngp, L.l.c. | Executive | Tender | 2,067,651 | $6.72 | $13.9M | Large |
| Jul 31, 2017 | Ngp, L.l.c. | Executive | Tender | 249,462 | $6.72 | $1.7M | Large |
| Jul 31, 2017 | Ngp, L.l.c. | Executive | Tender | 833,845 | $6.72 | $5.6M | Large |
| Jul 31, 2017 | Ngp, L.l.c. | Executive | Tender | 915,583 | $6.72 | $6.2M | Large |
| Jul 31, 2017 | Ngp, L.l.c. | Executive | Tender | 899,268 | $6.72 | $6.0M | Large |
| Jul 31, 2017 | Ngp, L.l.c. | Executive | Tender | 122,006 | $6.72 | $819.9K | Large |
| Jul 31, 2017 | Ngp, L.l.c. | Executive | Tender | 2,648,696 | $6.72 | $17.8M | Large |
| Jul 31, 2017 | R. Landry Monica | Executive | Tender | 209,577 | $6.72 | $1.4M | Large |
| Jul 31, 2017 | R. Landry Monica | Executive | Tender | 2,067,651 | $6.72 | $13.9M | Large |
| Jul 31, 2017 | R. Landry Monica | Executive | Tender | 249,462 | $6.72 | $1.7M | Large |
| Jul 31, 2017 | R. Landry Monica | Executive | Tender | 122,006 | $6.72 | $819.9K | Large |
| Jul 31, 2017 | R. Landry Monica | Executive | Tender | 899,268 | $6.72 | $6.0M | Large |
| Jul 31, 2017 | R. Landry Monica | Executive | Tender | 833,845 | $6.72 | $5.6M | Large |
| Jul 31, 2017 | R. Landry Monica | Executive | Tender | 2,648,696 | $6.72 | $17.8M | Large |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Tender(U) | 16 | $106.8M | 73.3% |
Award(A) | 24 | $28.0M | 19.2% |
Purchase(P) | 52 | $5.5M | 3.8% |
Disposition(D) | 19 | $5.4M | 3.7% |
Exercise(M) | 93 | $47.8K | 0.0% |
Sale(S) | 1 | $432 | 0.0% |
Conversion(C) | 28 | $0 | 0.0% |
Insiders at Nexvet Biopharma plc are accumulating shares at an accelerated pace. With 21 insiders making 233 transactions totaling $5.5M in purchases versus $432 in sales, the net buying activity of $5.5M signals strong executive confidence. L.l.c. Ngp, (Executive) leads the buying activity with $67.4M in transactions across all time.